http://whatstrading.com/2009/07/02/matri... atrix Initiatives (MTXX) is up $1.17 to $6.65 and options volume is running 4X the usual after a recent report seemed to ease concerns about an FDA review of the company (Link to story). Shares are up and buyers are showing interest in July 7.5 and 10 calls. It looks like some investors might be anticipating additional strength in the short-term. Since Friday is a holiday, markets are closed, and July options only have 10 trading days of life remaining after today. Meanwhile, in MTXX, implied volatility remains elevated and moving higher, up to 135 from about 119 the day before.
WASHINGTON, July 2 (Reuters) - In a Food and Drug Administration inspection document of a Matrixx Initiatives plant released on Thursday: * FDA inspector says Matrixx official said coordination of various procedures has improved over time. * FDA inspector says Matrixx official later said company had "nearly completed an extensive revision" of complaint proceedures. * The FDA released the report on its website at http://www.fda.gov/downloads/AboutFDA/Ce... ronicReadingRoom/UCM170136.pdf (Reporting by Susan Heavey; Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.
Market Data 
Markets 
